Zinc Completed Phase 2 Trials for Central Serous Chorioretinopathy (CSC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00963131High-dose Antioxidants for Central Serous Chorioretinopathy